Informace o publikaci

Molecular characterization of the rare translocation t(3;10)(q26;q21) in an acute myeloid leukemia patient

Autoři

JANCUSKOVA T PLACHY R ZEMANKOVA L HARDEKOPF DW ŠTIKA Jiří ZEJSKOVA L PRAULICH I KREUZER KA ROTHE A OTHMAN MAK KOSYAKOVA N PEKOVA S

Rok publikování 2014
Druh Článek v odborném periodiku
Časopis / Zdroj MOLECULAR CYTOGENETICS
Citace
Doi http://dx.doi.org/10.1186/1755-8166-7-47
Klíčová slova AML; MECOM; Chromosomal microdissection; Next-generation sequencing; Molecular marker
Popis Background: In acute myeloid leukemia (AML), the MDS1 and EVI1 complex locus - MECOM, also known as the ecotropic virus integration site 1 - EVI1, located in band 3q26, can be rearranged with a variety of partner chromosomes and partner genes. Here we report on a 57-year-old female with AML who presented with the rare translocation t(3;10) (q26;q21) involving the MECOM gene. Our aim was to identify the fusion partner on chromosome 10q21 and to characterize the precise nucleotide sequence of the chromosomal breakpoint. Methods: Cytogenetic and molecular-cytogenetic techniques, chromosome microdissection, next generation sequencing, long-range PCR and direct Sanger sequencing were used to map the chromosomal translocation. Results: Using a combination of cytogenetic and molecular approaches, we mapped the t(3;10)(q26;q21) to the single nucleotide level, revealing a fusion of the MECOM gene (3q26.2) and C10orf107 (10q21.2). Conclusions: The approach described here opens up new possibilities in characterizing acquired as well as congenital chromosomal aberrations. In addition, DNA sequences of chromosomal breakpoints may be a useful tool for unique molecular minimal residual disease target identification in acute leukemia patients.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info